BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26596832)

  • 21. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
    Huang H; Hu M; Zhao R; Li P; Li M
    Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
    Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
    Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the β-catenin/JNK/prothymosin-alpha axis as a novel target of sorafenib in hepatocellular carcinoma cells.
    Lin YT; Chao CC
    Oncotarget; 2015 Nov; 6(36):38999-9017. PubMed ID: 26517516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
    Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
    Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma.
    Yang N; Fu Y; Zhang H; Sima H; Zhu N; Yang G
    Oncotarget; 2015 Sep; 6(29):28151-63. PubMed ID: 26305675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
    Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
    Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.
    Huang NC; Huang RL; Huang XF; Chang KF; Lee CJ; Hsiao CY; Lee SC; Tsai NM
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
    Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
    Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis.
    Zhang B; Lai Y; Li Y; Shu N; Wang Z; Wang Y; Li Y; Chen Z
    Eur J Pharmacol; 2018 Feb; 821():57-67. PubMed ID: 29277717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
    Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
    Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S; Ye J; Yin M; Yu R
    Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.